Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors

de Oliveira ÉA. et al, (2021), Pharmacological Research, 105911 - 105911

MITF induces escape from innate immunity in melanoma.

Sánchez-Del-Campo L. et al, (2021), J Exp Clin Cancer Res, 40

Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-Hypoxic Conditions

Martí-Díaz R. et al, (2020), Cancers, 13, 102 - 102

Paradoxical activation of AMPK by glucose drives selective EP300 activity in colorectal cancer.

Gutiérrez-Salmerón M. et al, (2020), PLoS biology, 18

Organotypic Models in Drug Development "Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development".

de Oliveira ÉA. et al, (2020)

Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution

Louphrasitthiphol P. et al, (2020), Molecular Cell

Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.

Vivas-García Y. et al, (2020), Molecular cell, 77, 120 - 137.e9

ABCB5 is activated by MITF andβ‐catenin and is associated with melanoma differentiation

Louphrasitthiphol P. et al, (2019), Pigment Cell & Melanoma Research

MITF controls the TCA cycle to modulate the melanoma hypoxia response.

Louphrasitthiphol P. et al, (2019), Pigment Cell Melanoma Res

MITF-the first 25 years.

Goding CR. and Arnheiter H., (2019), Genes Dev

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice.

Li Y. et al, (2019), Nat Commun, 10

BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.

Herbert K. et al, (2019), Genes Dev, 33, 310 - 332

Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.

Yin C. et al, (2019), Cell, 176, 1113 - 1127.e16

Targeting MC1R depalmitoylation to prevent melanomagenesis in redheads.

Chen S. et al, (2019), Nat Commun, 10

Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming.

García-Jiménez C. and Goding CR., (2019), Cell Metab, 29, 254 - 267

A TFEB nuclear export signal integrates amino acid supply and glucose availability

Li L. et al, (2018), Nature Communications, 9

The protective role of DOT1L in UV-induced melanomagenesis

Zhu B. et al, (2018), Nature Communications, 9

BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export

Ngeow KC. et al, (2018), Proceedings of the National Academy of Sciences, 115, E8668 - E8677

Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy

Zhu B. et al, (2018), Oncogene, 37, 4941 - 4954

Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target

Apps JR. et al, (2018), Acta Neuropathologica, 135, 757 - 777

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?

In this section